Cargando…

Predicting IVF outcome in poor ovarian responders

BACKGROUND: Poor responders to ovarian stimulation are one of the most challenging populations to treat. As a failed cycle can cause a considerable emotional and economical loss, adequate fertility counseling addressing patients’ expectations are highly important when facing patients with poor ovari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lebovitz, Oshrit, Haas, Jigal, Mor, Nitzan, Zilberberg, Eran, Aizer, Adva, Kirshenbaum, Michal, Orvieto, Raoul, Nahum, Ravit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524122/ https://www.ncbi.nlm.nih.gov/pubmed/36180882 http://dx.doi.org/10.1186/s12905-022-01964-y

Ejemplares similares

Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
por: Shapira, Moran, et al.
Publicado: (2020)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
por: Orvieto, Raoul, et al.
Publicado: (2020)

Future fertility of patients with zero oocytes yield in their first IVF cycle attempt
por: Orvieto, Raoul, et al.
Publicado: (2021)

Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?
por: Orvieto, Raoul, et al.
Publicado: (2021)

Does mRNA SARS-CoV-2 vaccine detrimentally affect male fertility, as reflected by semen analysis?
por: Lifshitz, Dror, et al.
Publicado: (2022)

Elective egg freezing patients may benefit from increasing the maximal daily gonadotropin dose above 300IU
por: Orvieto, Raoul, et al.
Publicado: (2022)

The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome
por: Aizer, Adva, et al.
Publicado: (2022)

Influence of seasonal variation on in vitro fertilization success
por: Kirshenbaum, Michal, et al.
Publicado: (2018)

Recombinant follicular stimulating hormone plus recombinant luteinizing hormone versus human menopausal gonadotropins- does the source of LH bioactivity affect ovarian stimulation outcome?
por: Kirshenbaum, M., et al.
Publicado: (2021)

Dysregulation of anti-Mullerian hormone expression levels in mural granulosa cells of FMR1 premutation carriers
por: Friedman-Gohas, Moran, et al.
Publicado: (2021)

Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report
por: Haas, Jigal, et al.
Publicado: (2014)

The in-vitro effect of gonadotropins’ type and combination on Granulosa cells gene expressions
por: Yung, Yuval, et al.
Publicado: (2022)

Comment on “The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders”
por: Orvieto, Raoul
Publicado: (2015)

Does bariatric surgery improve ovarian stimulation characteristics, oocyte yield, or embryo quality?
por: Tsur, Abraham, et al.
Publicado: (2014)

Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?
por: Haas, Jigal, et al.
Publicado: (2017)

ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation
por: Bercaire, Ludmila, et al.
Publicado: (2018)

Can expelled cells/debris from a developing embryo be used for PGT?
por: Aizer, Adva, et al.
Publicado: (2021)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

Elevated Levels of FMR1 mRNA in Granulosa Cells Are Associated with Low Ovarian Reserve in FMR1 Premutation Carriers
por: Elizur, Shai E., et al.
Publicado: (2014)

Is Day-4 morula biopsy a feasible alternative for preimplantation genetic testing?
por: Orvieto, Raoul, et al.
Publicado: (2020)

Should We Offer In Vitro Fertilization to Couples with Unexplained Recurrent Pregnancy Loss?
por: Kirshenbaum, Michal, et al.
Publicado: (2019)

What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?
por: Blumenfeld, Zeev
Publicado: (2020)

Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome-a preliminary proof of concept
por: Orvieto, Raoul, et al.
Publicado: (2014)

Degenerated oocyte in the cohort adversely affects IVF outcome
por: Atzmon, Yuval, et al.
Publicado: (2020)

Pregnancy outcome in severe OHSS patients following ascitic/plerural fluid drainage
por: Haas, Jigal, et al.
Publicado: (2014)

Is Embryo Cryopreservation Causing Macrosomia—and What Else?
por: Orvieto, Raoul, et al.
Publicado: (2020)

Do human embryos have the ability of self-correction?
por: Orvieto, Raoul, et al.
Publicado: (2020)

Management of Poor Responders in IVF: Is There Anything New?
por: Ubaldi, Filippo, et al.
Publicado: (2014)

More is not always better–lower estradiol to mature oocyte ratio improved IVF outcomes
por: Aslih, Nardin, et al.
Publicado: (2021)

Strategies for Pituitary Down-regulation to Optimize IVF/ICSI Outcome in Poor Ovarian Responders
por: Badawy, Ahmed, et al.
Publicado: (2012)

Researching the Phenomenon of Poor Ovarian Responders and Management Strategies in IVF: A Narrative Review
por: Galatis, Dionysios, et al.
Publicado: (2022)

The myths surrounding mild stimulation in vitro fertilization (IVF)
por: Orvieto, Raoul, et al.
Publicado: (2017)

Development and Validation of a Clinical Pregnancy Failure Prediction Model for Poor Ovarian Responders During IVF/ICSI
por: Li, Fangyuan, et al.
Publicado: (2021)

Cleavage-stage human embryo arrest, is it embryo genetic composition or others?
por: Orvieto, Raoul, et al.
Publicado: (2022)

Effect of pretreatment with transdermal testosterone on poor ovarian responders undergoing IVF/ICSI: A meta-analysis
por: LUO, SHAN, et al.
Publicado: (2014)

Pregnancy Outcomes in Double Stimulation versus Two Consecutive Mild Stimulations for IVF in Poor Ovarian Responders
por: Li, Jingzhe, et al.
Publicado: (2022)

Poor responders in in vitro fertilization (IVF) therapy: the challenge continues
por: Oehninger, S.
Publicado: (2011)

The effects of Covid-19 mRNA vaccine on adolescence gynecological well-being
por: Mohr-Sasson, Aya, et al.
Publicado: (2023)

“Short agonist stop” protocol, an ovarian stimulation for poor responders in in vitro fertilization (IVF): A pilot study
por: Mauries, Charlotte, et al.
Publicado: (2022)

HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept
por: Haas, Jigal, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_98uc8ina18bhhs802rf6bls1iq